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We investigated the acute and subacute toxicities of hydro-ethanolic extract of leaves of Senna alata 
(L.) Roxb. in Swiss mice and Wistar albino rats. The mice were divided into 6 groups of 10 animals and 
each group received once by intra-gastric gavages 0, 4, 8, 12, 16, 20 times 1000 mg/kg dose of extract. 
Distilled water served as the control. For the subacute toxicity, three groups of 10 rats (5 males and 5 
females) were treated per os with distilled water (control), 500 or 1000 mg/kg of extract every 48 h for 26 
days. At the end of treatment blood sample and 20% liver homogenates were collected for biochemical 
analyses. The results indicated that the medium lethal dose (LD50) was about 18.50 g/kg of body weight. 
Significant variation (P<0.05)  of the body weight  was observed after 26 days of treatment,  in some 
biochemicals index of serum and 20% liver homogenates (glutathione , alkaline phosphatase (APL), 
aspartate aminotransferase (AST)), haematological parameters (platelet) also in the female relative 
weight of heart of  rat. Some of  parameter investigated in this study showed dose responsive. The 
histopatological study of the liver did not show any features after the treatment but, the extract seems 
to ameliorate the liver architecture. 
 





The traditional use of plant in the treatment of different 
infections is widely practised in Cameroon and other 
developing countries. The World Health Organization has 
recommended that this should be encouraged especially 
in countries where access to the conventional treatment 
is not adequate (WHO, 1980).  For this reason, various 
medicinal plants have been studied using modern 
scientific approaches. The studies have shown that due 
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plants have a variety of properties and can be used to 
treat various diseases.  
Senna alata (L) Roxb. belongs  to    Ceasalpiniaceae  
family. This plant grows in several regions of Cameroon 
and can also be found in other countries (Palanichamy et 
al., 1990; Ibrahim et al., 1995; Awal et al., 2004). In 
Cameroon, the leaves and stem bark of S. alata are used 
to treat hepatitis, skin diseases, jaundice, gastroenteritis, 
intestinal helminthiasis, eczema, tryphoenteritis and 
ringworm. The young leaves are used in rural areas to 
treat constispation and food poisoning. In Bangladesh 
various parts of the plants are often used for boils 
carbuncles, cut wound, foul ulcer, dysentery, ringworm, 
itches   eczema,   helminthiasis   and   various   intestinal  




troubles (Awal et al., 2004; Adjanohou et al., 1996 Ghani, 
1998). Some authors have reported the antifungal 
activity of the leaves of this plant. Awal et al. (2004) 
showed that the leaves of S. alata have antibacterial 
activity on Gram positive and negative bacteria (Sarcina 
lutea, Bacillus megaterium, Streptococcus hemlyticus,  
Staphylococus aureus, Salmonella thyphi, Esherichia 
coli, Pseudomonas aeruginosa and Klebsiella 
pneumoniae), while its seeds exhibited little activity on K.  
pneumoniae and S. Lutea. So far, other workers have 
reported diverse biological properties of S. alata 
(Thamlikitkul et al., 1990; Moriyama et al., 2003). Despite 
the popular use of this plant in the area of pharmacology 
in Cameroon, no information has been given about its 
toxicity. This work is carried out to evaluate the acute 
and subacute toxicity of the hydro-ethanolic extract of the 
plant S. alata in mice and albino rats. In the subacute 
toxicity study, the effect of this extract on biochemical, 
hematological and histopathological parameters were 
investigated.                        
 
 
MATERIALS AND METHODS 
  
Plant material  
 
Fresh leaves of S. alata were collected near the Eloundem 
mountain in  Yaoundé, the capital city of Cameroon. The sample 
was identified at the National Herbarium and a voucher specimen 
was deposited there under the number 1871YA.    
 
 
Preparation of the extract 
 
The collected plant material was dried at room temperature 
(30±3°C), pulverized and finely sieved. The powder obtained (200 
g) was macerated in 1000 ml of a mixture of ethanol/water (4:1, 
v/v) for 72 h. The extract was filtered using Whatman filter paper N° 
1 and concentrated in an air circulating oven at 54°C until total 
dryness. The experiment was repeated twice and 25 g of hydro-





Sexually mature male and female Wistar albino rats (102-134 g) 
and sexually mature Swiss albino mice (15-27 g) were obtained 
from the animal laboratory of the Biochemistry Department of the 
Yaoundé I University, Cameroon. All the animals were kept under 
standard environmental condition (27±2°C). The animals had free 
access to water and standard diet. Rats and mice were deprived of 
food but not water (16-18 h) prior to administration of the extract. 
The principles of laboratory animal care were followed and the 
Department’s ethical comittee approved the use of the animals and 





The bioassays were conducted according to the World Health 
Organisation guideline for the evaluation of the safety and 
efficiency of herbal medicines
 
(WHO, 1992). For the study, Swiss 
albino mice were divided into six groups of 10 animals (5 males 





throughout the experiment. The remaining groups (2-6) received 
once 4, 8, 12, 16, 20 doses of 1000 mg/kg body weight of the 
extract, respectively. Observations were made and recorded 
systematically 1, 2, 4 and 24 h after substance administration. The 
visual observations included skin changes, mobility, aggressively,  
sensitivity to sound and pain, as well as respiratory movements. 
The number of  survivors  was  noted  after  24 h  and  the futher 8 
days where their  weights were recorded . The LD50 was then 






Three groups of 10 rats (5 males and 5 females) received by intra-
gastric gavages the plant extract at the dose of 500 mg/kg, 1000 
mg/kg body weight or distilled water (control) every 48 h for 26 
days. During the period of administration, the animals were 
weighed, and food and water intake were monitored. After 26 days, 
all surviving animals were fasted overnight. Animals were sacrificed 
by decapitation and blood samples were collected into heparinized 
tube for haematological parameters and non-heparinized centrifuge 
tubes. The liver, heart, kidney and lung were collected and 
weighed. After instantaneous washing, a part of the liver tissue was 
kept in frozen containers (-20°C) for further analysis of biochemical 






Blood collected into non heparinized tubes were then centrifuged at 
3000 rpm for 10 min. The serum separated was analysed to 
evaluate the liver enzymes. Aspartate aminotransferase (AST ) and 
alanine aminotransferase (ALT ) were assayed using the method of 
Reitman and Frankel (1957); alkaline phosphatase (ALP) was 
analysed by the method of Bessey et al. (1946) Lowry et al (1954);  
creatinine  by Barterls (1972); protein was evaluated by the method 
of Gornall et al. (1949); and cholesterol by the method of Zlatkis et 
al. (1952) modified by Taga et al. (1998).  The 20% liver 
homogenates were also subjected to the same biochemical 
estimation except that instead of cholesterol, glutathione was 





Blood samples collected in the heparinized tubes were used to 
investigate white blood cells (WBC), red blood cells (RBC) and 





Histopathological investigation of the liver were done according to 
the method described by Lamb (1981).The organ pieces (3-5 µm 
thick) were fixed in 10% formalin for 24 h and washed in running 
water for 24 h. Samples were dehydrated in an autotechnicon and 
then cleared in benzene to remove absolute alcohol. Embedding 
was done by passing the cleared samples through three cups 
containing molten paraffin at 50°C and then in a cubical block of 
paraffin made by the “L” moulds. It was followed by microtome and 





Values were expressed as mean ± SD. The statistical analyses of 
variance was done by  ANOVA  followed  by  the  student-Newman  




                Table 1. Body weights of rats in sub acute toxicity after 26 days of oral administration of hydro-ethanolic extract of S. alata. 
 
Body weight (g) 
Female Day 0 Day 26 Weight gained in 26days 
Control 143.59 ± 7.37 169.25 ± 8.00 26.63 ± 5.30
a 
 (135.02-154.26) (164.02-183.55) (19.60-30.33) 
500 mg/kg 124.12 ±  18.65 156.36 ± 14.85 32.27 ± 16.15
b 
 (119.34-132.24) (136.98-172.82) (33.65-47.26) 
1000 mg/kg 132.81± 11.36 157.36 ± 15.75 24.55 ± 6.51
a 
 (116.84-142.89) (142.19 – 184.17) (20.09 – 35.37) 
Male 
Control 126.34 ±20.53 176.26 ± 29.26 49.72 ± 18.55b 
 (102.22- 158.87) (169.07 –189.53) (16.88 – 45.11) 




–158.87) (169.02 – 189.53) (12.21 –45.11) 
1000 mg/kg 161.42 ± 15.93 162.38 ± 6.35 33.93 ± 16.65
a 
 (113.29 – 148.05) (153.32 –171.06) (16.67 –46.68) 
                                           
Values are expressed as mean±SD. Parentheses are expressed as range values, n=5. Means with the same letter superscript 








RESULTS AND DISCUSSION 
 
The extraction of 200 g of sample gave a yield of 12.5%. 
Although the hydro-ethanol extract was used for the  
study, ethanol was included in the extraction to enhance 
different bioactive components, tannins, polyphenols and 
saponins. Moreover, the Cameroonian population only 
takes the aqueous preparations for their diseases.In the 
acute toxicity, mice treated with the dose of 20 g/kg body 
weight  showed some behavioral changes 120 min after 
oral administration. These changes included slow 
response to external stimuli, reduction of mobility and 
aggression, slight excitability sketching and 
sluggishness. However, after 24 h all the changes 
observed before disappeared. On the contrary, no 
adverse changes were noted in mice treated with less 
than 12 g/kg body weight. Death of mice was noted at 16 
and 20 g/kg. Weight gain recorded was increased in both 
sexes 8 days after oral administration of S. alata. The 
LD50 value obtained  was 18.5 g/kg body weight. 
According to Schorderet (1992), subtances with LD50 
values greater than 5 g/kg of body weight are considered 
to show low toxicity. Thus the aqueous ethanol extract of 
S. alata can be classified in the category of substances 
with low toxicity. 
In the subacute toxicity, the hydro-ethanol extract of S. 
alata at doses of 5000 mg/kg and 1000 mg/kg given per 
os every 48 h for 26 days did not result in death of the 
animals.  No sign of observable toxicity was detected 
during the experimental period. According to the OECD 
guideline, if an acute toxicity test at one dose level of at 
least 500 mg/kg body weight produced no observable 
toxic effects (Witthawaskyl et al., 2003), the full study at 
a dose of 1000 mg/kg given once daily for 14 days can 
be used to evaluate subacute toxicity. Rats treated with 
various doses of hydro-ethanolic extract of S.alata had a 
progressive weight gained. This increase in weight is 
significantly different (P< 0.05) from that of the control 
(Table 1). The progressive increase in body weight at 
doses of 500 and 1000 mg/kg of female and male rats 
during 26 days (Figure 1 and 2) of administration of 
aqueous ethanol extract of S. alata may indicate the 
improvement of the nutritional state of the animal. The 
growth response effect could be as the result of 
increased food and water intake.  
As shown in Table 3, the calculated relative weights of 
the control and treated animals groups varied from one 
organ to another. For the hearts and livers from the  
control group, the relative weights were quite similar to 
those of the treated groups (female and male rats). A 
decrease of the values of hearts were observed in the 
female control group with significant difference (P<0.05) 
in both organs of female group with significant difference 
(P<0.05) in the heart values. No significant differences 
(P<0.05) were noted in the relative weights of the other 
organs (liver, lung, kidney). However, there is no 
correlation between the relative weights of the organ and 
the doses of the extract of S. alata administered. 
The haematological status (Table 2) after 26 days of 
oral administration of hydroalcoholic extract of S. alata 
was also assessed. No significant variation (P<0.05) for 
RBC and WBC were observed. However, the variation 
was significantly different (P<0.05) for platelets.  In gene- 




Table 2. Haematological values of   rats in sub acute toxicity after 26 days of administration of hydroethanolic extract 
of S. alata. 
 














Control 2.02 ± 1.11 3.29 ± 1.40 2.03 ± 0.29
a
 
(1.20 – 2.31) (2.36 – 5.80) (1.52 – 2.32) 
500 mg/kg 2.21 ± 0.59 3.35  ±  1.46 2.87 ± 0.62
a
 
(1.62 –5.27) (2.02  - 5.76) (2.01 – 3.50) 
1000 mg/kg              2.33 ± 0.6 4.50 ± 1.05 3.05 ± 0.15
b
 
(1.60 – 2.82) (3.36 – 5.28) (2.94 – 3.28) 
Male       
Control 2.60 ± 1.74 3.38 ± 0.38 1.18 ± 0.14
a
 
(1.62 – 2.27) (2.60 – 3.23) (0.76 – 1.32) 
500 mg/kg              2.73 ± 1.11 3.44 ± 1.74 1.38 ± 0.25
a
 
(1.21 – 4.41) (3.08 – 3.88) (0.81 – 1.6) 
1000 mg/kg            2.96 ± 1.51 3.50 ± 0.88 2.52 ± 0.09
b
 
(2.20 – 3.60) (3.04 – 4.72) (0.76 – 3.12) 
 
Values are expressed as mean±SD,  n=5. Parentheses are expressed as range values. Means with the same letter 































Figure 1. Effect of hydro-ethanolic extract of S. alata on the 




ral the results showed that the values for the RBC and 
WBC were slightly increased in female and male groups 
compared to the  control.  The  small  transient  of values 
observed in blood haematology did not show any dose 
responsiveness. Thus the hydroalcoholic extract of S. 
alata affect slightly some haematological parameters. 
Results of biochemical analyses in both female and male 
rats are shown in the Tables 4 and 5 for the serum and 
the 20% liver homogenate, respectively. After 26 days 
dosage of hydroalcoholic extract of S. alata, there were 
no significant changes in alanine aminotransferase 
(ALT), aspartate aminotransferase (AST) and alkaline 
phosphatase (APL) activities in the serum of both sexes 





























Figure 2: Effect of hydro-ethanolic extract of S. alata on the 
body weight of male rats during the subacute toxicity. Each 




A small but not significantly different (p<0.05) increase 
was noted on alkaline phophatase (APL) activities of the 
serum in both sexes and 20% liver homogenate in the 
female group only. This variation of APL activity was 
statistically different (P<0.05) in the 20% homogenate 
from male liver. In the same group, a slight reduction of 
the level of ALT and APL were noted with statistical 
differences (P<0.05). ALT and AST are two liver 
enzymes that are associated to the hepatocellular 
damage. Although both AST and ALT are common liver 
enzymes because of their higher concentrations in 
hepatocytes, only ALT is remarkably specific for liver  




Table 3. Weights of organs of rats (g/100g of body weights) in sub acute toxicity of hydro ethanolic extract  
S. alata. 
                 
Treatment   (mg/kg)    Heart Lung Kidney Liver 
Female 
Control 0.40 ± 0.01
b
 0.58 ± 0.02 0.61 ± 0.08 3.55 ± 0.34 
(0.38 – 0.42) (0.58 – 0.62) (0.57 – 0.74) (3.71 – 3.98) 
500 mg/kg            0.37 ± 0.05 
b
 0.61 ± 0.01 0.71 ± 0.07 3.50 ± 0.17 
(.28 – 0.41) (0.59 – 0.3) (0.62 – 0.79) (3.38 –3.84) 
1000 mg/kg           0.31 ± 0.06
a
 0.64 ± 0.06 0.71 ± 0.14 3.67 ± 0.27 
(0.26 – 0.47) (0.58 – 0.74) (0.55 – 0.94) (3.33 – 3.84) 
Male 
Control  0.37 ± 0.08 0.58 ± 0.11 0.66 ± 0.13 3.31± 0.11 
( 0.31 – 0.52) (0.44 – 0.71) (0.54 – 0.87) (3.17- 3.47) 
500 mg/kg      0.30 ± 0.02 0.62 ± 0.06 0.68 ± 0.11 3.33 ± 0.18 
(0.29 – 0.39) (0.53 – 0.71) (0.55 – 0.71) (3.12 – 3.61) 
1000 mg/kg    0.37 ± 0.04 0.63 ± 0.02 0.74 ± 0.10 3.43 ± 0.27 
(0.30 – 0.39) (0.53 – 0.66) (0.73 – 0.82) (3.24 – 3.91) 
 
Values are expressed as mean±SD. Parentheses are expressed as range values, n=5.  Means with the same letter 
superscript within a column in each group (sex) are not significantly different (P<0.05). 
 
 
Table 4. Blood biochemical indices of rats in  sub acute toxicity of  hydro-ethanolic   extract of S. alata. 
 
Biochemical indices Treatment (mg/kg ) 
Control 500 mg/kg 1000 mg/kg 
Female 
ALT (UI/ml)            40.01 ± 0.12 40.06 ± 0.25 39.77 ± 0.18 
(39.48 – 40.26) (39.88 – 40.39) (39.96 – 40.24) 
AST (UI/ml)             83.63 ±  0.06 83.66 ±  0.12 83.69  ± 0.05 
(83.56 – 83.68) (83.54 – 83.86) (83.69 – 83.76) 
APL (UI/ml) 46.34  ± 2.51 46.72 ± 2.40 47.49 ±  1.00 
(39.31 – 48.55 ) (46.02 – 48.45) (43.52 – 49.50) 
Creatinine (mg/ml)        16.61 ± 1.27 15.85 ± 0.41 16.34 ± 0.47 
(12.50 – 16.66) (15.85 – 0.41) (16.34 – 0.47) 
Protein (mg/ml)         0.17 ± 0.01 0.17 ± 0.02 0.16 ± 0.02 
0.17 ± 0.01 0.17 ± 0.02 0.16 ± 0.02 
Cholesterol (g/L) 2.04 ± 0.39 2.05 ± 0.40 1.85 ± 0.14 
(1.64 – 2.84) (1.52 – 2.39) (1.71 – 1.93) 
Male  
ALT (UI/ml)            40.01 ± 0.12 40.06 ± 0.25 39.77 ± 0.18 
(39.91 – 40.23) (0.00 – 40.14) (39.77 – 40.31) 
AST (UI/ml)             83.80 ± 0.15 83.88 ± 0.28 83.73 ± 0.07 
(83.68 – 84.06) (83.72 – 84.39) (83.62 – 83.82) 
APL (UI/ml) 48.56 ± 0.75 48.59 ± 0.45 48.70 ± 0.59 
(47.04 – 49.05) (47.97 – 48.98) (47.97 – 49.05) 
 
 




                    Table 3. cont’d 
 
Creatinine (mg/ml)        16.20 ± 0.42
a
 15.69 ± 0.72 
a
 17.46 ± 1.07
b
 
(13.33 – 16.66) (14.95 – 16.60) (15.50 – 20.00) 
Protein (mg/ml)         0.16 ± 0.03 0.19  ± 0.04 0.17 ± 0.00 
(0.14 – 0.20) (0.17 – 0.21) (1.71 – 1.93) 
Cholesterol (g/ml) 2.23 ± 0.49 1.94 ± 0.32 1.83 ± 0.07 
(1.64 – 2.84) (1.52 – 2.39) (1.71 – 1.93) 
 
Values are expressed as mean±SD. Parentheses are expressed as range values, n=5.  Means with the same letter 




function since AST is mostly present in the myocardium, 
skeletal muscle, brain and kidneys (McIntyre et al., 1987; 
Witthawaskul et al., 2003).  In general with liver disease, 
serum levels of AST and ALT rise and fall at the same 
time (Sacher et al., 1991). A mild elevation of AST level 
has been shown to be associated with liver injury or 
myocardial infarctions (Stroev, 1989). The higher the 
activity of AST, the larger the infarctions size (Roberts et 
al., 1975; Haweroft, 1987). This result indicates that the 
hydroalcoholic extract of S. alata when taken for long 
periods of time may not cause liver disease. A typical 
myocardial infarction gives an AST/ALT ratio greater 
than 1 while an AST/ALT ratio less than  1 is  as a  result 
the release of ALT from the affected liver (Haweroft, 
1987).
  
AST/ALT ratio of more than 2 indicates alcoholic 
hepatitis or cirrchosis (McIntyre et al., 1987). However, 
this result did not show any dose responsive effect from 
the results of ALT, AST, and APL. The liver glutathione 
level increases gradually at doses of 500 and 1000mg/kg 
body weight compared to the control after 26 days of  
administration. This increased level of glutathione is not 
statistically significant (P<0.05) for the male but this 
variation was significantly different (P<0.05) for the 
female. 
The histopatological study of the liver of differents 
groups of rats showed a normal architecture. Rats 
treated orally with the extract of S. alata for 26 days, 
showed little abnomalities such as steatosis, clarification 
and balloning of hepatocytes. These signs not found in 
the control groups are mostly seen in the rats which 
received 1000 mg/kg body weight. The presence of 
steatosis also in the control groups suggested that this 
may be caused by diet of the animals. However no 
necrosis, infiltration, oedema and conjunction, which are  
the signs of hepatotoxicity were found. The effect of S. 
alata seems to have a protective effect on hepatocytes 
and improves liver architecture.  
In conclusion, this study presents strong evidence of 
the nontoxic effect of the hydroethanolic extract of S. 
alata. These results showed that the use of the extract of 
S. alata is safe and explained the extensive utilisation of 
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